Harmed by Phenobarbital SJS? Top California Attorneys
If you developed Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN) after using phenobarbital, you may be able to pursue compensation in California. Below we explain potential claims (including failure-to-warn and manufacturing-defect theories), who may be liable, key evidence, deadlines, and next steps. For help now, contact our California product liability team.
Understanding Phenobarbital, SJS, and TEN
Phenobarbital is a barbiturate used to treat seizures. In rare cases, certain medicines—including some anti-seizure drugs—are associated with severe cutaneous adverse reactions such as SJS and its more extensive form, TEN. Early symptoms can be flu-like, followed by a painful rash, blistering, skin detachment, and mucous membrane involvement. These are medical emergencies that often require hospitalization and can lead to long-term complications. See safety overviews from the FDA and clinical summaries in StatPearls, which discuss anticonvulsants (including phenobarbital) among implicated drugs.
Potential Legal Theories in California
- Product liability (prescription drugs): Claims may include manufacturing defect and failure to warn. Under California law, strict liability design-defect claims against prescription drug manufacturers are generally not permitted (Brown v. Superior Court). Failure-to-warn theories remain available and include duties tied to known or reasonably knowable risks (Carlin v. Superior Court).
- Negligence: Allegations may involve negligent testing, labeling, pharmacovigilance, or failure to update warnings when new risk information emerges.
- Medical negligence: Claims may arise if prescribers did not meet the standard of care in prescribing, monitoring, recognizing early SJS/TEN signs, or promptly discontinuing suspected causative drugs.
- Pharmacies/other providers: Duties can be limited and fact-specific in California. Liability, if any, depends on the circumstances and applicable standards of care.
Who May Be Liable
Potential defendants can include a brand-name manufacturer, a generic manufacturer (subject to federal preemption limits), distributors, and in some cases healthcare providers. Federal law generally preempts failure-to-warn and design-defect claims against generic manufacturers (PLIVA v. Mensing; Mutual Pharmaceutical v. Bartlett). In California, however, courts have allowed certain negligence-based failure-to-warn claims against a brand-name manufacturer even when the injured patient took a generic version (T.H. v. Novartis). Liability turns on what was known or knowable about risk at the time, the adequacy of warnings, and causation.
Evidence That Strengthens an SJS/TEN Case
- Hospital, burn unit, and dermatology records confirming SJS/TEN and extent of skin/mucosal involvement
- Biopsy/specialist notes, medication administration records, and differential diagnosis
- Prescription history showing phenobarbital start date, dose, and recent medication changes
- Photographs of the rash and progression; wound-care and ophthalmology notes
- History of label changes, adverse event reports, and expert opinions (dermatology, pharmacology, ophthalmology)
- Employment, wage, and caregiving records to establish economic losses
Practical Tips
- Do not restart suspected culprit drugs unless a specialist advises otherwise.
- Ask for copies of discharge summaries and pathology reports before leaving the hospital.
- Keep a simple log of pain levels, vision changes, and wound care—it can support damages.
How Causation Is Evaluated
Attorneys and experts assess timing of symptom onset relative to starting or changing phenobarbital, rule out alternative causes, and consider medical literature on drug-associated SJS/TEN. They also evaluate whether warnings adequately addressed the risk, whether safer alternatives were considered, and whether earlier discontinuation could have reduced harm.
Damages You May Recover
Depending on the facts and defendants, recoverable damages may include medical expenses (hospitalization, ICU/burn care, wound care, ophthalmology), future care and rehabilitation, lost income and diminished earning capacity, pain and suffering, disfigurement, and—if applicable—wrongful death damages for eligible heirs. Punitive damages may be available where supported by clear and convincing evidence under California law. Note that statutory caps may apply to certain medical malpractice noneconomic damages (Cal. Civ. Code § 3333.2).
Deadlines Can Be Short—Act Promptly
California generally imposes a two-year statute of limitations for personal injury and wrongful death claims (Cal. Code Civ. Proc. § 335.1), and a separate one-year/three-year framework for medical malpractice (Cal. Code Civ. Proc. § 340.5), subject to discovery rules and other exceptions. Some claims have shorter notice requirements. Because timing rules are complex and missing a deadline can bar recovery, speak with a California attorney promptly.
What to Do If You Suspect SJS/TEN from Phenobarbital
- Seek emergency medical care and follow specialist guidance
- Preserve medication bottles, packaging, and patient leaflets
- Create a timeline of symptoms, ER visits, hospitalizations, and medication changes
- Request copies of all medical records and pathology/biopsy reports
- Limit social media posts about the incident until you have legal advice
- Contact a California product liability attorney experienced with SJS/TEN cases
How Our California SJS Lawyer Help
We investigate quickly, consult qualified experts, secure hospital and pharmacy records, analyze label histories, and evaluate liability against all potential defendants. We negotiate with insurers and litigate in court while you focus on recovery. Most clients pay no upfront fees—our fees are typically contingent on recovery.
Free, Confidential Consultation
If you or a loved one suffered SJS or TEN after taking phenobarbital, contact our team for a free case evaluation. We will explain your rights, key deadlines, and next steps.
FAQ
How soon after starting phenobarbital can SJS/TEN appear?
Onset often occurs within the first few weeks after starting or changing a dose, but timing varies. Seek immediate medical care if symptoms arise.
Can I bring a claim if I took a generic?
Federal preemption limits claims against generic manufacturers, but California permits certain negligence-based failure-to-warn claims against brand-name manufacturers in some circumstances.
What compensation is available?
Medical costs, lost income, pain and suffering, disfigurement, and, in some cases, punitive damages and wrongful death damages.
What should I bring to a consultation?
Medication bottles, hospital records, discharge summaries, photos of injuries, and a symptom timeline.
Is there a fee to get started?
Most cases are handled on a contingency fee basis—no upfront fees, and attorney fees are paid from any recovery.
Talk to a California SJS Lawyer Today
Time limits apply. For prompt help tailored to California law, schedule your free consultation now.
Sources
- FDA — SJS/TEN Safety Information
- StatPearls (NCBI Bookshelf) — Stevens-Johnson Syndrome
- California OAG — Product Liability Overview
- Brown v. Superior Court, 44 Cal.3d 1049 (1988)
- Carlin v. Superior Court, 13 Cal.4th 1104 (1996)
- T.H. v. Novartis Pharm. Corp., 4 Cal.5th 145 (2017)
- PLIVA, Inc. v. Mensing, 564 U.S. 604 (2011)
- Mutual Pharmaceutical Co. v. Bartlett, 570 U.S. 472 (2013)
- Cal. Code Civ. Proc. § 335.1
- Cal. Code Civ. Proc. § 340.5
- Cal. Civ. Code § 3333.2